Chang Sun to Crystallization
This is a "connection" page, showing publications Chang Sun has written about Crystallization.
Connection Strength
6.246
-
Crystal and Particle Engineering Strategies for Improving Powder Compression and Flow Properties to Enable Continuous Tablet Manufacturing by Direct Compression. J Pharm Sci. 2018 04; 107(4):968-974.
Score: 0.601
-
Origin of two modes of non-isothermal crystallization of glasses produced by milling. Pharm Res. 2012 Apr; 29(4):1020-32.
Score: 0.397
-
On the identification of slip planes in organic crystals based on attachment energy calculation. J Pharm Sci. 2008 Aug; 97(8):3456-61.
Score: 0.314
-
Solid-state properties and crystallization behavior of PHA-739521 polymorphs. Int J Pharm. 2006 Aug 17; 319(1-2):114-20.
Score: 0.268
-
Modulating Pharmaceutical Properties of Berberine Chloride through Cocrystallization with Benzendiol Isomers. Pharm Res. 2023 Dec; 40(12):2791-2800.
Score: 0.219
-
Complexation with aromatic carboxylic acids expands the solid-state landscape of berberine. Int J Pharm. 2022 Apr 05; 617:121587.
Score: 0.201
-
Simultaneous improvement of physical stability, dissolution, bioavailability, and antithrombus efficacy of Aspirin and Ligustrazine through cocrystallization. Int J Pharm. 2022 Mar 25; 616:121541.
Score: 0.200
-
The efficient development of a sildenafil orally disintegrating tablet using a material sparing and expedited approach. Int J Pharm. 2020 Nov 15; 589:119816.
Score: 0.181
-
Material-Sparing and Expedited Development of a Tablet Formulation of Carbamazepine Glutaric Acid Cocrystal- a QbD Approach. Pharm Res. 2020 Jul 23; 37(8):153.
Score: 0.180
-
Molecular Origin of the Distinct Tabletability of Loratadine and Desloratadine: Role of the Bonding Area - Bonding Strength Interplay. Pharm Res. 2020 Jun 28; 37(7):133.
Score: 0.179
-
Recent Advances in Co-processed APIs and Proposals for Enabling Commercialization of These Transformative Technologies. Mol Pharm. 2020 07 06; 17(7):2232-2244.
Score: 0.179
-
Reduction of Punch-Sticking Propensity of Celecoxib by Spherical Crystallization via Polymer Assisted Quasi-Emulsion Solvent Diffusion. Mol Pharm. 2020 04 06; 17(4):1387-1396.
Score: 0.176
-
Microstructures and pharmaceutical properties of ferulic acid agglomerates prepared by different spherical crystallization methods. Int J Pharm. 2020 Jan 25; 574:118914.
Score: 0.172
-
Relationship between hydrate stability and accuracy of true density measured by helium pycnometry. Int J Pharm. 2019 Aug 15; 567:118444.
Score: 0.167
-
Expedited Tablet Formulation Development of a Highly Soluble Carbamazepine Cocrystal Enabled by Precipitation Inhibition in Diffusion Layer. Pharm Res. 2019 Apr 23; 36(6):90.
Score: 0.165
-
Computational Techniques for Predicting Mechanical Properties of Organic Crystals: A Systematic Evaluation. Mol Pharm. 2019 04 01; 16(4):1732-1741.
Score: 0.164
-
Direct Compression Tablet Containing 99% Active Ingredient-A Tale of Spherical Crystallization. J Pharm Sci. 2019 04; 108(4):1396-1400.
Score: 0.160
-
Improving solid-state properties of berberine chloride through forming a salt cocrystal with citric acid. Int J Pharm. 2019 Jan 10; 554:14-20.
Score: 0.160
-
Relating the tableting behavior of piroxicam polytypes to their crystal structures using energy-vector models. Int J Pharm. 2018 May 30; 543(1-2):46-51.
Score: 0.153
-
Improving Dissolution Rate of Carbamazepine-Glutaric Acid Cocrystal Through Solubilization by Excess Coformer. Pharm Res. 2017 12 29; 35(1):4.
Score: 0.151
-
Mechanical Properties and Tableting Behavior of Amorphous Solid Dispersions. J Pharm Sci. 2017 01; 106(1):217-223.
Score: 0.139
-
Enabling the Tablet Product Development of 5-Fluorocytosine by Conjugate Acid Base Cocrystals. J Pharm Sci. 2016 06; 105(6):1960-1966.
Score: 0.135
-
The development of carbamazepine-succinic acid cocrystal tablet formulations with improved in vitro and in vivo performance. Drug Dev Ind Pharm. 2016; 42(6):969-76.
Score: 0.129
-
Effect of heating rate and kinetic model selection on activation energy of nonisothermal crystallization of amorphous felodipine. J Pharm Sci. 2014 Dec; 103(12):3950-3957.
Score: 0.121
-
Enabling tablet product development of 5-fluorocytosine through integrated crystal and particle engineering. J Pharm Sci. 2014 Apr; 103(4):1126-32.
Score: 0.115
-
Design, synthesis, and characterization of new 5-fluorocytosine salts. Mol Pharm. 2013 Jun 03; 10(6):2462-6.
Score: 0.110
-
Cocrystallization for successful drug delivery. Expert Opin Drug Deliv. 2013 Feb; 10(2):201-13.
Score: 0.106
-
Preparation and characterization of surface-engineered coarse microcrystalline cellulose through dry coating with silica nanoparticles. J Pharm Sci. 2012 Nov; 101(11):4258-66.
Score: 0.104
-
Simultaneously improving the mechanical properties, dissolution performance, and hygroscopicity of ibuprofen and flurbiprofen by cocrystallization with nicotinamide. Pharm Res. 2012 Jul; 29(7):1854-65.
Score: 0.101
-
Overcoming poor tabletability of pharmaceutical crystals by surface modification. Pharm Res. 2011 Dec; 28(12):3248-55.
Score: 0.096
-
Materials science tetrahedron--a useful tool for pharmaceutical research and development. J Pharm Sci. 2009 May; 98(5):1671-87.
Score: 0.083
-
Influence of crystal structure on the tableting properties of n-alkyl 4-hydroxybenzoate esters (parabens). J Pharm Sci. 2007 Dec; 96(12):3324-33.
Score: 0.075
-
Thermal expansion of organic crystals and precision of calculated crystal density: a survey of Cambridge Crystal Database. J Pharm Sci. 2007 May; 96(5):1043-52.
Score: 0.072
-
A material-sparing method for simultaneous determination of true density and powder compaction properties--aspartame as an example. Int J Pharm. 2006 Dec 01; 326(1-2):94-9.
Score: 0.068
-
Improved tableting properties of p-hydroxybenzoic acid by water of crystallization: a molecular insight. Pharm Res. 2004 Feb; 21(2):382-6.
Score: 0.058
-
Development of direct compression Acetazolamide tablet with improved bioavailability in healthy human volunteers enabled by cocrystallization with p-Aminobenzoic acid. Int J Pharm. 2024 Mar 05; 652:123793.
Score: 0.057
-
A Rheological Approach for Predicting Physical Stability of Amorphous Solid Dispersions. J Pharm Sci. 2023 01; 112(1):204-212.
Score: 0.052
-
Molecular Interpretation of the Compaction Performance and Mechanical Properties of Caffeine Cocrystals: A Polymorphic Study. Mol Pharm. 2020 01 06; 17(1):21-31.
Score: 0.043
-
Effects of Water on Powder Flowability of Diverse Powders Assessed by Complimentary Techniques. J Pharm Sci. 2019 08; 108(8):2613-2620.
Score: 0.041
-
Polymer Nanocoating of Amorphous Drugs for Improving Stability, Dissolution, Powder Flow, and Tabletability: The Case of Chitosan-Coated Indomethacin. Mol Pharm. 2019 03 04; 16(3):1305-1311.
Score: 0.041
-
Dapagliflozin-citric acid cocrystal showing better solid state properties than dapagliflozin. Eur J Pharm Sci. 2017 Jun 15; 104:255-261.
Score: 0.036
-
Resveratrol cocrystals with enhanced solubility and tabletability. Int J Pharm. 2016 Jul 25; 509(1-2):391-399.
Score: 0.034
-
Probing interfaces between pharmaceutical crystals and polymers by neutron reflectometry. Mol Pharm. 2012 Jul 02; 9(7):1953-61.
Score: 0.026
-
A study of sulfamerazine single crystals using atomic force microscopy, transmission light microscopy, and Raman spectroscopy. J Pharm Sci. 2005 Sep; 94(9):1881-92.
Score: 0.016